Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–10 of 10 results
Advanced filters: Author: Daphne Zohar Clear advanced filters

  • A selection of individuals from the biotech ecosystem give their views on the challenges facing the sector over the coming years.

    • Anu Acharya
    • Kate Bingham
    • Daphne Zohar
    Special Features
    Nature Biotechnology
    Volume: 34, P: 276-283

  • Digital medicine is poised to transform biomedical research, clinical practice and the commercial sector. Here we introduce a monthly column from R&D/venture creation firm PureTech tracking digital medicine's emergence.

    • Eric Elenko
    • Lindsay Underwood
    • Daphne Zohar
    Comments & Opinion
    Nature Biotechnology
    Volume: 33, P: 456-461

  • Clear and logical regulatory guidelines on the process and requirements for approval of health apps and wearable sensors will be essential for the digital medicine sector to unleash its full potential.

    • Eric Elenko
    • Austin Speier
    • Daphne Zohar
    Comments & Opinion
    Nature Biotechnology
    Volume: 33, P: 697-702

  • Digital medicine companies can incorporate and build on existing business models in tech and biomedicine to bring transformational new products to market and eventually reshape medicine.

    • David Steinberg
    • Geoffrey Horwitz
    • Daphne Zohar
    Comments & Opinion
    Nature Biotechnology
    Volume: 33, P: 910-920

  • Digital medicine offers the possibility of continuous monitoring, behavior modification and personalized interventions at low cost, potentially easing the burden of chronic disease in cost-constrained healthcare systems.

    • Joseph C Kvedar
    • Alexander L Fogel
    • Daphne Zohar
    Comments & Opinion
    Nature Biotechnology
    Volume: 34, P: 239-246